recurrent squamous cell carcinoma of the oropharynx
Showing 1 - 25 of >10,000
Squamous Cell Carcinoma of the Oropharynx Trial in Paris (Tumor Biopsy)
Not yet recruiting
- Squamous Cell Carcinoma of the Oropharynx
- Tumor Biopsy
-
Paris, France
- +2 more
Sep 25, 2023
Squamous Cell Carcinoma of the Oropharynx, Squamous Cell Carcinoma of the Larynx, Squamous Cell Carcinoma of the Oral Cavity
Active, not recruiting
- Squamous Cell Carcinoma of the Oropharynx
- +7 more
-
Tampa, Florida
- +2 more
Dec 30, 2022
Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Squamous Cell Carcinoma of the Hypopharynx, Metastatic Squamous
Active, not recruiting
- Metastatic Head and Neck Squamous Cell Carcinoma
- +9 more
- Carboplatin
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Apr 27, 2022
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With
Completed
- Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
- +35 more
- PI3K inhibitor BKM120
- cetuximab
-
Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
Sep 14, 2021
Head and Neck Squamous Cell Carcinoma, Cancer, Cancer of Head and Neck Trial in United States (Pembrolizumab, Radiation therapy,
Recruiting
- Head and Neck Squamous Cell Carcinoma
- +14 more
- Pembrolizumab
- +2 more
-
Tucson, Arizona
- +6 more
Oct 7, 2021
Following Salvage Surgery for RESidual or reCurrent sqUamous
Not yet recruiting
- Head and Neck Cancer
- Molecular Analyses
- (no location specified)
Mar 28, 2023
Recurrent Head Neck Cancer, Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Carcinoma Trial in Saint
Not yet recruiting
- Recurrent Head and Neck Cancer
- +5 more
-
Saint Louis, MissouriWashington University School of Medicine
Jul 30, 2023
Squamous Cell Carcinoma of the Oral Cavity or Oropharynx Trial (Black Raspberry)
Not yet recruiting
- Squamous Cell Carcinoma of the Oral Cavity or Oropharynx
- Black Raspberry
- (no location specified)
Oct 16, 2023
Squamous Cell Carcinoma of the Oropharynx, HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Carmel, Indianapolis (44
Recruiting
- Squamous Cell Carcinoma of the Oropharynx
- HPV Positive Oropharyngeal Squamous Cell Carcinoma
- 44 doses of radiation
- 54 doses of radiation
-
Carmel, Indiana
- +1 more
Oct 5, 2022
Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell
Completed
- Stage IV Squamous Cell Carcinoma of the Hypopharynx
- +3 more
-
Boston, Massachusetts
- +1 more
Feb 11, 2021
Esophageal Squamous Cell Carcinoma Trial (Fruquintinib Combined With Camrelizumab, Paclitaxel Liposome and Nedaplatin)
Not yet recruiting
- Esophageal Squamous Cell Carcinoma
- Fruquintinib Combined With Camrelizumab, Paclitaxel Liposome and Nedaplatin
- (no location specified)
Aug 17, 2023
HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Orange (Intensity-Modulated Radiation Therapy (IMRT))
Recruiting
- HPV Positive Oropharyngeal Squamous Cell Carcinoma
- Intensity-Modulated Radiation Therapy (IMRT)
-
Orange, CaliforniaChao Family Comprehensive Cancer Center, University of Californi
Nov 4, 2022
Head and Neck Squamous Cell Carcinoma Trial (Zanzalintinib, Zanzalintinib-matched Placebo, Pembrolizumab)
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- Zanzalintinib
- +2 more
- (no location specified)
Oct 9, 2023
Squamous Cell Carcinoma, Oropharynx Cancer, Head Neck Cancer Trial in Houston (SAR444245, Cemiplimab)
Not yet recruiting
- Squamous Cell Carcinoma
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Sep 7, 2022
Squamous Cell Carcinoma of the Oral Cavity, Squamous Cell Carcinoma of the Larynx, Squamous Cell Carcinoma of the Hypopharynx
Not yet recruiting
- Squamous Cell Carcinoma of the Oral Cavity
- +3 more
- Eliminating RT to the elective neck
- RT standard of care
-
Erlangen, Bavaria, GermanyUniversitätsklinikum Erlangen, Strahlenklinik
Sep 8, 2023
Squamous Cell Carcinoma of the Oropharynx Trial in United States (Radiation Therapy)
Not yet recruiting
- Squamous Cell Carcinoma of the Oropharynx
- Radiation Therapy
-
Miami, Florida
- +3 more
Jul 22, 2023
Squamous Cell Carcinoma of Head and Neck, Locally Advanced Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck
Not yet recruiting
- Squamous Cell Carcinoma of Head and Neck
- +2 more
- RP3
- +3 more
- (no location specified)
Feb 21, 2023
Oropharynx Squamous Cell Carcinoma Trial in Ann Arbor (Nivolumab, Carboplatin, Paclitaxel)
Active, not recruiting
- Oropharynx Squamous Cell Carcinoma
- Nivolumab
- +3 more
-
Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
Dec 20, 2022
Squamous Cell Carcinoma Trial (MK-3475A)
Not yet recruiting
- Squamous Cell Carcinoma
- MK-3475A
- (no location specified)
Sep 11, 2023
Head and Neck Squamous Cell Carcinoma, Head Neck Cancer Trial (Tislelizumab, BGB-A425, LBL-007)
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- Head and Neck Cancer
- Tislelizumab
- +2 more
- (no location specified)
Jun 9, 2023
Head Neck Cancer, Head and Neck Squamous Cell Carcinoma, Oropharynx Cancer Trial in United States (other, radiation, diagnostic
Not yet recruiting
- Head and Neck Cancer
- +4 more
- Experimental Observation
- +3 more
-
Baltimore, Maryland
- +5 more
Oct 16, 2023
Metastatic Head-and-neck Squamous-cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma Trial (Ficlatuzumab,
Not yet recruiting
- Metastatic Head-and-neck Squamous-cell Carcinoma
- Recurrent Head and Neck Squamous Cell Carcinoma
- Ficlatuzumab
- +2 more
- (no location specified)
Sep 26, 2023
Head Neck, Squamous Cell Carcinoma of Head and Neck Trial in Houston (Pembrolizumab, Magrolimab, cetuximab)
Not yet recruiting
- Head Neck
- Squamous Cell Carcinoma of Head and Neck
- Pembrolizumab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Sep 14, 2023
Head and Neck Squamous Cell Carcinoma Trial (TTI-101, Pembrolizumab)
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- (no location specified)
Dec 20, 2022